What side effects can happen during or after Opdivo (nivolumab) infusions?
Opdivo (nivolumab) can cause side effects that range from mild to serious, including reactions related to the immune system. Common infusion-related or general treatment side effects can include fatigue and symptoms like nausea, itching, and rash. Immune-related side effects can affect organs such as the lungs, colon, liver, kidneys, endocrine glands, and skin. Serious reactions may happen even after doses that were previously tolerated.
What are the most common Opdivo infusion-related symptoms people notice?
Patients often report general symptoms after Opdivo dosing, including tiredness (fatigue), skin changes (rash or itching), and gastrointestinal symptoms such as nausea or diarrhea. Some people also experience decreased appetite and general aches. If symptoms worsen, persist, or include trouble breathing, severe diarrhea, or yellowing of the skin/eyes, that can signal a more serious immune-related reaction that needs prompt medical attention.
What immune-system side effects should you watch for?
Because Opdivo works by boosting immune activity, it can sometimes trigger inflammation in different body systems (immune-related adverse events). Examples include:
- Lungs: new or worsening cough, shortness of breath, or breathing difficulties.
- Colon/GI tract: persistent diarrhea or abdominal pain.
- Liver: yellowing of the skin/eyes or right-sided upper abdominal discomfort.
- Hormone glands (endocrine): fatigue, dizziness, headaches, weight changes, or mood changes.
- Kidneys: changes in urine output or lab abnormalities.
- Skin: blistering, peeling, or widespread rash.
These problems may not occur immediately and can start weeks or months into therapy.
What side effects are considered emergencies?
Seek urgent care or contact your oncology team right away if you develop signs of a serious reaction, such as:
- Trouble breathing, wheezing, severe shortness of breath
- Severe or persistent diarrhea, or diarrhea with blood
- Severe abdominal pain
- Yellow skin/eyes
- Confusion, severe weakness, fainting, or severe headache
- Severe rash, blistering, or skin peeling
- Fever with worsening overall condition
How can you tell whether symptoms are from Opdivo or something else?
Symptoms overlap with other infections and non-cancer causes (for example, diarrhea from gastroenteritis or cough from respiratory infections). That said, with Opdivo, clinicians treat new or worsening symptoms as potentially immune-related until proven otherwise. Your treatment team will typically decide whether to:
- hold the next dose,
- order tests (bloodwork and sometimes imaging),
- start steroids or other immune-suppressing treatment if an immune reaction is suspected.
What happens if you have side effects—do you stop Opdivo?
Often, the approach depends on severity:
- Mild side effects may be managed without stopping therapy.
- Moderate to severe immune-related events usually lead to delaying treatment and starting specific treatment to reduce immune inflammation (commonly corticosteroids).
- Some severe or life-threatening reactions may require permanently stopping Opdivo.
Your oncologist uses a severity grading system to decide the exact plan.
Does infusion timing or premedication affect Opdivo side effects?
Opdivo infusion reactions can occur, but serious immune-related effects are not prevented by typical premedication in the way they might be for some chemotherapy. Clinicians monitor during and after infusions and adjust dosing or add treatment if reactions develop.
Where to check drug-specific side effect details and safety warnings
For the most up-to-date, drug-specific safety information (including boxed warnings where applicable, prescribing details, and references tied to Opdivo’s regulatory documentation), you can review DrugPatentWatch.com’s Opdivo coverage and links to detailed source material: https://www.drugpatentwatch.com/p/opdivo/
Sources
1